Karim Mikhail
Algemeen Directeur bij Amarin Pharma, Inc.
Vermogen: 923 854 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Karim Mikhail
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 33 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Karim Mikhail via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| SARISSA CAPITAL ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Georgetown University Law Center | College/University | Graduate Degree Graduate Degree | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| INFLARX N.V. | Biotechnology | General Counsel Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Amarin Pharma, Inc.
 Amarin Pharma, Inc. Pharmaceuticals: MajorHealth Technology Amarin Pharma, Inc. operates as a biopharmaceutical research company. The company was founded in 2007 and is headquartered in Bedminster, NJ. | Pharmaceuticals: Major | Corporate Secretary Chief Executive Officer | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| CYTEIR THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
| CHIASMA, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact Director/Board Member | |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Seton Hall University | College/University | Undergraduate Degree Masters Business Admin | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| VALERITAS HOLDINGS, INC. | Medical Specialties | Chief Executive Officer | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
| HURON CONSULTING GROUP INC. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Taro Pharmaceuticals U.S.A., Inc.
 Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Pharmaceuticals: Generic | Director of Finance/CFO | |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
| State University of New York at Albany | College/University | Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PARATEK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ARMATA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Yale New Haven Health Services Corp.
 Yale New Haven Health Services Corp. Miscellaneous Commercial ServicesCommercial Services Yale-New Haven Health Services Corp. operates as a non-profit organization that provides healthcare services. It offers geriatrics, oncology, neurology and neurosurgery, orthopedics, primary care, transplantation, clinical programs and services, health education, and research and clinical trials. The company was founded in 1995 and is headquartered in New Haven, CT. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Illinois At Urbana–Champaign | College/University | Masters Business Admin | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Pharmaceuticals: Major | Director/Board Member | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
| The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| VALERITAS INC | Medical Specialties | Chief Executive Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Prothena Biosciences, Inc.
 Prothena Biosciences, Inc. BiotechnologyHealth Technology Part of Prothena Corp. Plc, Prothena Biosciences, Inc. is a company that specializes in the biology of misfolded proteins. The company is based in South San Francisco, CA. The company has over 3 decades of expertise in this field and offer a range of services including science, pipeline, clinical trial information, and more. | Biotechnology | Chairman | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 41 |
| Canada | 3 |
| Ierland | 3 |
| Verenigd Koninkrijk | 3 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 35 |
| Finance | 7 |
| Consumer Services | 7 |
| Commercial Services | 5 |
Operationeel
| Director/Board Member | 150 |
| Corporate Officer/Principal | 68 |
| Independent Dir/Board Member | 65 |
| Chairman | 36 |
| Undergraduate Degree | 25 |
Sterkste connecties
| Insiders | |
|---|---|
| Joseph Zakrzewski | 30 |
| David Stack | 27 |
| Per Wold-Olsen | 24 |
| Lars Ekman | 21 |
| Erin Enright | 19 |
| Keith Horn | 19 |
| Kristine Peterson | 18 |
| Alfonso Zulueta | 16 |
| Jan van Heek | 15 |
| Alan J. Wills | 13 |
| John Thero | 11 |
| Lisa M. DeFrancesco | 11 |
| Patrick O’Sullivan | 11 |
| David Keenan | 11 |
| Jason Marks | 11 |
- Beurs
- Insiders
- Karim Mikhail
- Bedrijfsconnecties
